GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,851.00
-26.00 (-1.39%)
Sep 25, 2026, 4:35 PM GMT
GSK plc Market Cap
GSK plc has a market cap or net worth of 75.21 billion as of September 25, 2026. Its market cap has increased by 25.83% in one year.
Market Cap
75.21B
Enterprise Value
89.93B
Revenue
33.20B
Ranking
n/a
PE Ratio
15.93
Stock Price
1,851.00
ChartMarket Cap Chart
Since April 12, 2000, GSK plc's market cap has increased from 67.16B to 75.21B, an increase of 11.98%. That is a compound annual growth rate of 0.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 75.21B | 2.75% |
| Dec 31, 2025 | 73.20B | 33.23% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 192.33B |
| Haleon | 30.38B |
| Smith & Nephew | 8.45B |
| Convatec Group | 4.14B |
| Hikma Pharmaceuticals | 3.42B |
| HUTCHMED (China) | 1.89B |
| Oxford Nanopore Technologies | 1.71B |
| Genus | 1.39B |